Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-on Therapy in Symptomatic Subjects with Pulmonary Arterial Hypertension (PAH).
Epistemonikos ID: 9c041b8edf491f91a69b7eb681bc260c70814c22
First added on: May 10, 2024